IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · IEX Real-Time Price · USD
42.39
+0.10 (0.24%)
Jul 26, 2024, 4:00 PM EDT - Market closed
IDEAYA Biosciences Market Cap
IDEAYA Biosciences has a market cap or net worth of $3.56 billion as of July 26, 2024. Its market cap has increased by 174.78% in one year.
Market Cap
3.56B
Enterprise Value
2.87B
1-Year Change
174.78%
Ranking
Category
Stock Price
$42.39
Market Cap Chart
Since May 23, 2019, IDEAYA Biosciences's market cap has increased from $218.00M to $3.56B, an increase of 1,534.20%. That is a compound annual growth rate of 71.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 3.20B | 39.56% |
| Dec 29, 2023 | 2.29B | 162.35% |
| Dec 30, 2022 | 874.20M | -3.94% |
| Dec 31, 2021 | 910.10M | 123.61% |
| Dec 31, 2020 | 407.00M | 166.89% |
| Dec 31, 2019 | 152.50M | -30.05% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmunityBio | 3.69B |
| Merus | 3.69B |
| Neogen | 3.64B |
| Arrowhead Pharmaceuticals | 3.59B |
| Corcept Therapeutics | 3.59B |
| Alvotech | 3.50B |
| Prestige Consumer Healthcare | 3.50B |
| Axonics | 3.47B |